<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001740791</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001631487</issuerCik>
      <issuerName>CollPlant Biotechnologies Ltd</issuerName>
      <secFileNumber>001-38370</secFileNumber>
      <issuerAddress>
        <com:street1>4 OPPENHEIMER ST., 11TH FLOOR</com:street1>
        <com:city>REHOVOT</com:city>
        <com:stateOrCountry>OH</com:stateOrCountry>
        <com:zipCode>74140</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>972-73-232-5600</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Sagy Ami</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Credit Suisse Securities (USA) LLC</name>
        <address>
          <com:street1>Eleven Madison Avenue</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10010</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>110000</noOfUnitsSold>
      <aggregateMarketValue>798600.00</aggregateMarketValue>
      <noOfUnitsOutstanding>11186481</noOfUnitsOutstanding>
      <approxSaleDate>06/14/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <acquiredDate>02/17/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Private Placement</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Collplant Biotechnologies Ltd.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>250000</amountOfSecuritiesAcquired>
      <paymentDate>02/17/2021</paymentDate>
      <natureOfPayment>Wire Payment</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>06/14/2023</noticeDate>
      <signature>Ami Sagy</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2779}]
144
0001740791
XXXXXXXX
LIVE
0001631487
CollPlant Biotechnologies Ltd
001-38370
4 OPPENHEIMER ST., 11TH FLOOR
REHOVOT
OH
74140
972-73-232-5600
Sagy Ami
10% Stockholder
Ordinary Shares
Credit Suisse Securities (USA) LLC
Eleven Madison Avenue
New York
NY
10010
110000
798600.00
11186481
06/14/2023
NASDAQ
Ordinary Shares
02/17/2021
Private Placement
Collplant Biotechnologies Ltd.
N
250000
02/17/2021
Wire Payment
Y
06/14/2023
Ami Sagy